Form 424B3 Elevance Health, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Elevance (ELV) PT Lowered to $548 at JPMorgan
October 23, 2024 4:13 PM EDTJPMorgan analyst Lisa Gill lowered the price target on Elevance (NYSE: ELV) to $548.00 (from $655.00) while maintaining a Overweight rating.
The analyst comments "ELV owns the most recognizable national brand and operates with leading market share in its commercial licensed BCBS markets.... More
